Single Mutation in Hammerhead Ribozyme Favors Cleavage Activity with Manganese Over Magnesium
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Biophysical and Biochemical Investigations of RNA Catalysis in the Hammerhead Ribozyme
UC Santa Cruz UC Santa Cruz Previously Published Works Title Biophysical and biochemical investigations of RNA catalysis in the hammerhead ribozyme. Permalink https://escholarship.org/uc/item/366835vs Journal Quarterly reviews of biophysics, 32(3) ISSN 0033-5835 Author Scott, WG Publication Date 1999-08-01 DOI 10.1017/s003358350000353x Peer reviewed eScholarship.org Powered by the California Digital Library University of California Quarterly Reviews of Biophysics 32, 3 (1999), pp. 241–284 Printed in the United Kingdom 241 # 1999 Cambridge University Press Biophysical and biochemical investigations of RNA catalysis in the hammerhead ribozyme William G. Scott The Center for the Molecular Biology of RNA and the Department of Chemistry and Biochemistry, Sinsheimer Laboratories, University of California at Santa Cruz, Santa Cruz, California 95064, USA 1. How do ribozymes work? 241 2. The hammerhead RNA as a prototype ribozyme 242 2.1 RNA enzymes 242 2.2 Satellite self-cleaving RNAs 242 2.3 Hammerhead RNAs and hammerhead ribozymes 244 3. The chemical mechanism of hammerhead RNA self-cleavage 246 3.1 Phosphodiester isomerization via an SN2(P) reaction 247 3.2 The canonical role of divalent metal ions in the hammerhead ribozyme reaction 251 3.3 The hammerhead ribozyme does not actually require metal ions for catalysis 254 3.4 Hammerhead RNA enzyme kinetics 257 4. Sequence requirements for hammerhead RNA self-cleavage 260 4.1 The conserved core, mutagenesis and functional group modifications 260 4.2 Ground-state vs. transition-state effects 261 -
Gene Therapy Glossary of Terms
GENE THERAPY GLOSSARY OF TERMS A • Phase 3: A phase of research to describe clinical trials • Allele: one of two or more alternative forms of a gene that that gather more information about a drug’s safety and arise by mutation and are found at the same place on a effectiveness by studying different populations and chromosome. different dosages and by using the drug in combination • Adeno-Associated Virus: A single stranded DNA virus that has with other drugs. These studies typically involve more not been found to cause disease in humans. This type of virus participants.7 is the most frequently used in gene therapy.1 • Phase 4: A phase of research to describe clinical trials • Adenovirus: A member of a family of viruses that can cause occurring after FDA has approved a drug for marketing. infections in the respiratory tract, eye, and gastrointestinal They include post market requirement and commitment tract. studies that are required of or agreed to by the study • Adeno-Associated Virus Vector: Adeno viruses used as sponsor. These trials gather additional information about a vehicles for genes, whose core genetic material has been drug’s safety, efficacy, or optimal use.8 removed and replaced by the FVIII- or FIX-gene • Codon: a sequence of three nucleotides in DNA or RNA • Amino Acids: building block of a protein that gives instructions to add a specific amino acid to an • Antibody: a protein produced by immune cells called B-cells elongating protein in response to a foreign molecule; acts by binding to the • CRISPR: a family of DNA sequences that can be cleaved by molecule and often making it inactive or targeting it for specific enzymes, and therefore serve as a guide to cut out destruction and insert genes. -
How Might a Pre-Biotic Ribozyme Catalyze RNA Assembly in an RNA World?
Science Highlight – April 2007 How Might a Pre-biotic Ribozyme Catalyze RNA Assembly in an RNA World? Which came first, nucleic acids or proteins? This question is molecular biology's version of the "chicken-or-the-egg" riddle. Genes made of nucleic acids (DNA or RNA) contain the instructions for making proteins, but enzymes made of proteins are needed to replicate genes. For those who try to understand how life origi- nated, this once seemed an intractable paradox. The discovery 25 years ago that RNA can be enzymatic permits us to speculate that pre-biotic self-replicating molecules may have been RNAs (1,2). This is known as the "RNA World" hypothesis, and with the discovery of RNA catalysis, it is now possible to imagine a prebiotic The L1 Ligase ribozyme at the moment 'RNA World' (or even one populated by early life forms) of bond creation. in which self-replicating ribozymes (RNA-based enzymes that possess the catalytic ability to copy themselves) accomplished both tasks, thus avoiding the potential “chicken-or-the-egg” conundrum (3). But there's a catch. In order to copy RNA, fragments or monomers that have 5'-triphosphates must be ligated together. This is true for modern polymerases, and is also the most likely mechanism by which a ribozyme self-replicase in an RNA World might function. Yet no one has found a modern natural ribozyme that catalyze this The RNA nucleotide triphosphate ligation reaction required reaction (pictured right). for RNA polymerization and self-replication. RNA in vitro evolution and selection has however enabled several research groups to discover RNA sequences that can in fact cata- lyze the required chemical reaction (shown above) for 5'-triphos- phate RNA fragment ligation, and one group has even produced a primitive but functional RNA-based RNA polymerase ribozyme (4). -
Kinetic Characterization of Ribozymes Directed Against the Cisplatin
D2001 Nature Publishing Group 0929-1903/01/$17.00/+0 www.nature.com/cgt Kinetic characterization of ribozymes directed against the cisplatin resistance±associated ABC transporter cMOAT/MRP2/ABCC2 Verena Materna, Per Sonne Holm, Manfred Dietel, and Hermann Lage Institute of Pathology, Charite Campus Mitte, Humboldt University Berlin, Berlin D-10117, Germany. The enhanced expression of the human ABC transporter, cMOAT (MRP2/ABCC2), is associated with resistance of tumor cells against platinum-containing compounds, such as cisplatin. Therefore, cMOAT represents an interesting candidate factor for modulation of antineoplastic drug resistance. Two different hammerhead ribozymes, which exhibit high catalytic cleavage activities towards specific RNA sequences encoding cMOAT, were designed. Cleavage sites of these ribozymes are the GUC sites in codons 704 and 708 of the open readingframe in the cMOAT-specific mRNA molecule. Hammerhead ribozymes were in vitro synthesized using bacteriophage T7 RNA polymerase and oligonucleotide primers whereby one primer contains a T7 RNA polymerase promoter sequence. cMOAT-encodingsubstrate RNA molecules were created by a reverse transcription polymerase chain reaction usingRNA prepared from the cisplatin-resistant human ovarian carcinoma cell line A2780RCIS overexpressingthe cMOAT-encoding transcript. In a cell-free system, both anti-cMOAT ribozymes cleaved their substrate in a highly efficient manner at a physiologic pH and temperature. The cleavage reaction was dependent on time and ribozyme:substrate ratio for determining specific kinetic parameters. Cancer Gene Therapy (2001) 8, 176±184 Key words: cMOAT; MRP2; ABCC2; ribozyme; drug resistance; cisplatin. cquirement of resistance to antineoplastic agents, at of a broad range of endogenous and xenobiotic compounds Aconcentrations which were once effective for cancer across the apical canalicular membrane of the hepatocyte.4 chemotherapy, is a major obstacle in the clinical treatment Mutations in the cMOAT-encoding gene were shown to of human malignancies. -
Mirna Research Guide Mirna Guide Cover Final.Qxd 9/28/05 10:24 AM Page 4
miRNA_guide_cover_final.qxd 9/28/05 10:24 AM Page 3 miRNA Research Guide miRNA_guide_cover_final.qxd 9/28/05 10:24 AM Page 4 Contents Introduction to microRNAs and Experimental Overview Introduction to microRNAs . .1 miRNA Experimental Overview . .2 microRNA Isolation and Enrichment miRNA Isolation . .3 mirVana™ miRNA Isolation Kits . .3 “miRNA Certified” FirstChoice® Total RNA . .3 RecoverAll™ Total Nucleic Acid Isolation Kit . .3 miRNA Enrichment . .4 flashPAGE™ Fractionator System . .4 Global microRNA Expression Profiling miRNA Expression Profiling . .5 Overview of the mirVana™ Array System . .6 mirVana™ miRNA Labeling Kit . .7 mirVana™ miRNA Probe Set . .7 mirVana™ miRNA Bioarrays . .8 Detection and Quantification of Specific microRNAs mirVana™ miRNA Detection Kit . .9 mirVana™ miRNA Probe and Market Kit . .9 mirVana™ miRNA Probe Construction Kit . .10 mirVana™ qRT-PCR miRNA Detection Kit . .11 microRNA Functional Analysis miRNA Functional Analysis . .12 Anti-miR™ miRNA Inhibitors . .12 Pre-miR™ miRNA Precursor Molecules . .13 siPORT™ NeoFX™ Transfection Agent . .13 pMIR-REPORT™ miRNA Expression Reporter Vector . .13 microRNA Information Resources miRNA Resource . .14 miRNA Database . .14 miRNA Array Resource . .14 Introduction to microRNAs . .14 miRNA Application Guide . .15 Technical miRNA Seminars . .15 Highly Trained miRNA Technical Support Scientists . .15 miRNA e-Updates . .15 TechNotes Newsletter . .15 Reference Relative miRNA Expression Among Common Cell Types . .16 miRNA_guide_guts_final.qxd 9/28/05 10:26 AM Page 1 Introduction to microRNAs and Experimental Overview Introduction to microRNAs Overview of microRNA processing Small regulators with global impact miRNAs are transcribed as regions of longer RNA molecules that can be as long as 1000 nt (Figure 3). Description of microRNAs MicroRNAs (miRNAs) are evolutionarily conserved, small, noncoding RNA mol- The longer RNA molecules are processed in the nucleus into hairpin RNAs of ecules that regulate gene expression at the level of translation (Figure 1). -
A Tetracycline-Dependent Ribozyme Switch Allows Conditional Induction of Gene Expression in Caenorhabditis Elegans
ARTICLE https://doi.org/10.1038/s41467-019-08412-w OPEN A tetracycline-dependent ribozyme switch allows conditional induction of gene expression in Caenorhabditis elegans Lena A. Wurmthaler1,2, Monika Sack1,2, Karina Gense2,3, Jörg S. Hartig1,2 & Martin Gamerdinger2,3 The nematode Caenorhabditis elegans represents an important research model. Convenient methods for conditional induction of gene expression in this organism are not available. Here 1234567890():,; we describe tetracycline-dependent ribozymes as versatile RNA-based genetic switches in C. elegans. Ribozyme insertion into the 3’-UTR converts any gene of interest into a tetracycline- inducible gene allowing temporal and, by using tissue-selective promoters, spatial control of expression in all developmental stages of the worm. Using the ribozyme switches we established inducible C. elegans polyglutamine Huntington’s disease models exhibiting ligand- controlled polyQ-huntingtin expression, inclusion body formation, and toxicity. Our approach circumvents the complicated expression of regulatory proteins. Moreover, only little coding space is necessary and natural promoters can be utilized. With these advantages tetracycline-dependent ribozymes significantly expand the genetic toolbox for C. elegans. 1 Department of Chemistry, University of Konstanz, 78457 Konstanz, Germany. 2 Konstanz Research School Chemical Biology (KoRS-CB), University of Konstanz, 78457 Konstanz, Germany. 3 Department of Biology, University of Konstanz, 78457 Konstanz, Germany. Correspondence and requests for materials should be addressed to J.S.H. (email: [email protected]) or to M.G. (email: [email protected]) NATURE COMMUNICATIONS | (2019) 10:491 | https://doi.org/10.1038/s41467-019-08412-w | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08412-w nducible regulatory systems are very powerful research tools to single A-to-G point mutation in the catalytic core of the HHR9 Iinvestigate the cellular function of individual genes. -
COMMENTARY Does Transcription by RNA Polymerase Play a Direct Role in the Initiation of Replication?
Journal of Cell Science 107, 1381-1387 (1994) 1381 Printed in Great Britain © The Company of Biologists Limited 1994 COMMENTARY Does transcription by RNA polymerase play a direct role in the initiation of replication? A. Bassim Hassan* and Peter R. Cook† CRC Nuclear Structure and Function Research Group, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK *Present address: Addenbrooke’s NHS Trust, Hills Rd, Cambridge CB2 2QQ, UK †Author for correspondence SUMMARY RNA polymerases have been implicated in the initiation of replication in bacteria. The conflicting evidence for a role in initiation in eukaryotes is reviewed. Key words: cell cycle, initiation, origin, replication, transcription PRIMERS AND PRIMASES complex becomes exclusively involved in the synthesis of Okazaki fragments on the lagging strand. A critical step in this DNA polymerases cannot initiate the synthesis of new DNA process is the unwinding of the duplex. chains, they can only elongate pre-existing primers. The opposite polarities of the two strands of the double helix coupled with the 5′r3′ polarity of the polymerase means that RNA POLYMERASES AND THE INITIATION OF replication occurs relatively continuously on one (leading) REPLICATION IN BACTERIA strand and discontinuously on the other (lagging) strand. The continuous strand probably needs to be primed once, usually The first evidence of a role for RNA polymerase came from at an origin. Nature has found many different ways of doing the demonstration that the initiation of replication in this, including the use of RNA primers made by an RNA poly- Escherichia coli was sensitive to rifampicin, an inhibitor of merase (e.g. -
Non-Coding Transcription Influences the Replication Initiation Program Through Chromatin Regulation
Downloaded from genome.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press Non-coding transcription influences the replication initiation program through chromatin regulation Julien Soudet1*, Jatinder Kaur Gill1 and Françoise Stutz1*. 1Dept. of Cell Biology, University of Geneva, Switzerland. *Correspondence: [email protected], [email protected] Keywords (10 words): non-coding RNA, non-coding transcription, histone modifications, nucleosomes, replication timing, replication initiation, yeast 1 Downloaded from genome.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT In Eukaryotic organisms, replication initiation follows a temporal program. Among the parameters that regulate this program in Saccharomyces cerevisiae, chromatin structure has been at the center of attention without considering the contribution of transcription. Here, we revisit the replication initiation program in the light of widespread genomic non-coding transcription. We find that non-coding RNA transcription termination in the vicinity of ARS (Autonomously Replicating Sequences) shields replication initiation from transcriptional readthrough. Consistently, high natural nascent transcription correlates with low ARS efficiency and late replication timing. High readthrough transcription is also linked to increased nucleosome occupancy and high levels of H3K36me3. Moreover, forcing ARS readthrough transcription promotes these chromatin features. Finally, replication initiation defects induced by increased transcriptional readthrough are partially rescued in the absence of H3K36 methylation. Altogether, these observations indicate that natural non-coding transcription into ARS influences replication initiation through chromatin regulation. 2 Downloaded from genome.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press INTRODUCTION DNA replication is a fundamental process occurring in all living organisms and ensuring accurate duplication of the genome. -
Ch 7 -Brock Information Flow in Biological Systems
Systems Microbiology Monday Oct 2 - Ch 7 -Brock Information flow in biological systems •• DNADNA replicationreplication •• TranscriptionTranscription •• TranslationTranslation Central Dogma DNA Replication Transcription Images removed due to copyright restrictions. RNA Reverse Transcription Translation Protein Flow of information replication DNA → DNA transcription ↓ RNA translation ↓ protein 5' end ring numbering system for -P-O-C deoxyribose 5’ -C O O 4’ 1’ P O- O 3’ 2’ C ssDNA 3’ end HO In a nucleotide, e.g., adenosine monophosphate (AMP), the base is bonded to a ribose sugar, which has a phosphate in ester linkage to the 5' hydroxyl. NH NH NH2 2 2 adenine N N N N N N N N N N N N H −2 HO O3P O CH CH 5' 2 O 2 O 4' H H 1' H H ribose H 3' 2' H H H OH OH OH OH adenine adenosine adenosine monophosphate (AMP) Nucleic acids have a NH2 backbone of adenine N N alternating Pi & ribose moieties. N NH − N 2 Phosphodiester 5' end O cytosine − 5' O P O CH N linkages form as the 2 O 4' 1' O H H ribose 5' phosphate of one N O H 3' 2' H nucleotide forms an O OH − 5' ester link with the 3' O P O CH 2 O OH of the adjacent O H H ribose nucleotide. H 3' H O OH − O P O (etc) nucleic acid 3' end O H N H O N Guanine Cytosine N H N N N N O H N Backbone Backbone Hydrogen H bond H O H N CH3 N Thymine N H N N Adenine N N Hydrogen O bond Backbone Backbone Figure by MIT OCW. -
Hammerhead Ribozymes Against Virus and Viroid Rnas
Hammerhead Ribozymes Against Virus and Viroid RNAs Alberto Carbonell, Ricardo Flores, and Selma Gago Contents 1 A Historical Overview: Hammerhead Ribozymes in Their Natural Context ................................................................... 412 2 Manipulating Cis-Acting Hammerheads to Act in Trans ................................. 414 3 A Critical Issue: Colocalization of Ribozyme and Substrate . .. .. ... .. .. .. .. .. ... .. .. .. .. 416 4 An Unanticipated Participant: Interactions Between Peripheral Loops of Natural Hammerheads Greatly Increase Their Self-Cleavage Activity ........................... 417 5 A New Generation of Trans-Acting Hammerheads Operating In Vitro and In Vivo at Physiological Concentrations of Magnesium . ...... 419 6 Trans-Cleavage In Vitro of Short RNA Substrates by Discontinuous and Extended Hammerheads ........................................... 420 7 Trans-Cleavage In Vitro of a Highly Structured RNA by Discontinuous and Extended Hammerheads ........................................... 421 8 Trans-Cleavage In Vivo of a Viroid RNA by an Extended PLMVd-Derived Hammerhead ........................................... 422 9 Concluding Remarks and Outlooks ........................................................ 424 References ....................................................................................... 425 Abstract The hammerhead ribozyme, a small catalytic motif that promotes self- cleavage of the RNAs in which it is found naturally embedded, can be manipulated to recognize and cleave specifically -
Structural Simplicity and Mechanistic Complexity in the Hammerhead Ribozyme
CHAPTER SEVEN Structural Simplicity and Mechanistic Complexity in the Hammerhead Ribozyme Sara M. O’Rourke, William G. Scott1 The Center for the Molecular Biology of RNA, University of California at Santa Cruz, Santa Cruz, CA, United States 1Corresponding author: e-mail address: [email protected] Contents 1. Background and Structural Overview 178 2. Fast Minimal Hammerhead Ribozymes 181 3. Acid-Base Catalysis and the Hammerhead Ribozyme 182 4. Is the Hammerhead Ligation Reaction the Reverse of the Cleavage Reaction? 191 5. Do Cooperative Interactions in the Hammerhead Ribozyme Facilitate General Base Catalysis in the Cleavage Reaction? 194 6. Summary and Concluding Remarks 195 6.1 The Structure of the Hammerhead Ribozyme May Be Much Simpler Than We Have Thought 196 6.2 The Mechanism of the Hammerhead Ribozyme May Be Much More Complicated Than We Have Thought 196 6.3 Concluding Remarks 200 References 201 Abstract Natural or full-length hammerhead ribozymes are up to 1000-fold more active than their minimal counterparts that lack a complex tertiary interaction that pre-organizes and stabilizes the ribozyme active site, positioning RNA functional groups to facilitate acid-base catalysis. The recent discovery that a single tertiary contact (an AU Hoogsteen pair) between Stems I and II confers essentially all of the enhanced activity greatly simplifies our understanding of the structural requirements for hammerhead ribozyme activity. In contrast, the simplest mechanistic interpretations are challenged with the presentation of more complex alternatives. These alternatives are elucidated and criti- cally analyzed in the context of several of the active hammerhead ribozyme structures now available. # Progress in Molecular Biology and Translational Science, Volume 159 2018 Elsevier Inc. -
Riboprobe(R) in Vitro Transcription Systems Technical Manual TM016
TECHNICAL MANUAL Riboprobe® in vitro Transcription Systems InstrucƟ ons for use of Products P1420, P1430, P1440, P1450 and P1460 Revised 10/13 TM016 tm016.1013:EIVD_TM.qxd 9/26/2013 11:10 AM Page 1 Riboprobe® in vitro Transcription Systems All technical literature is available on the Internet at www.promega.com/protocols Please visit the web site to verify that you are using the most current version of this Technical Manual. Please contact Promega Technical Services if you have questions on use of this system. E-mail [email protected] 1. Description..........................................................................................................1 2. Product Components.........................................................................................3 3. General Considerations....................................................................................4 A. Properties of Promega Vectors Suitable for in vitro Transcription ..............4 B. Applications of Promega Vectors ......................................................................6 C. General Cloning Techniques ..............................................................................6 4. RNA Transcription in vitro .............................................................................7 A. DNA Template Preparation................................................................................7 B. Synthesis of High-Specific-Activity Radiolabeled RNA Probes ...................8 C. Determining Percent Incorporation and Probe Specific Activity ...............10